LK
IMGN

Lumbard & Kellner’s Immunogen Inc IMGN Stock Holding History

Lumbard & Kellner’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-40,731
Closed -$83K – 88
2016
Q4 		$83K Sell
40,731
-310,834
-88% -$624K 0.05% 64
2016
Q3 		$942K Hold
351,565
– – 0.65% 37
2016
Q2 		$1.08M Buy
351,565
+183,250
+109% +$1.15M 0.8% 38
2016
Q1 		$1.43M Sell
168,315
-675
-0.4% -$5.71K 1.05% 28
2015
Q4 		$2.29M Buy
168,990
+1,965
+1% +$24.2K 1.69% 23
2015
Q3 		$1.6M Buy
167,025
+1,100
+0.7% +$16.1K 1.27% 27
2015
Q2 		$2.39M Sell
165,925
-1,740
-1% -$19.1K 1.7% 23
2015
Q1 		$1.5M Buy
167,665
+58,030
+53% +$420K 1.08% 34
2014
Q4 		$669K Buy
109,635
+12,935
+13% +$118K 0.47% 48
2014
Q3 		$1.02M Buy
96,700
+16,175
+20% +$183K 0.72% 42
2014
Q2 		$955K Sell
80,525
-700
-0.9% -$8.79K 0.68% 43
2014
Q1 		$1.19M Hold
81,225
– – 1.02% 36
2013
Q4 		$1.19M Buy
+81,225
New +$1.25M 1.02% 36

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lumbard & Kellner's IMGN Position: Q1 2017 in Review

Lumbard & Kellner sold out of Immunogen Inc (IMGN) in Q1 2017, closing a stake of 40,731 shares — an estimated $83K sold.

Lumbard & Kellner first reported a position in IMGN in Q4 2013 and held it in 13 quarters. The position peaked at $2.39M in Q2 2015. 135 funds tracked by Wall St. Rank hold IMGN as of Q1 2017.

  • Lumbard & Kellner reported no remaining Immunogen Inc position as of Q1 2017 after selling out during the quarter.
  • Lumbard & Kellner sold 40,731 Immunogen Inc shares in Q1 2017, an estimated $83K.
  • Lumbard & Kellner first reported a position in Immunogen Inc in Q4 2013 and held it in 13 quarters.
  • Lumbard & Kellner's Immunogen Inc position peaked at $2.39M in Q2 2015.
  • 135 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2017.

Based on Lumbard & Kellner's 13F filing for Q1 2017, filed 16 May 2017.